- Patent Title: Lytic domain fusion constructs and methods of making and using same
-
Application No.: US14038631Application Date: 2013-09-26
-
Publication No.: US09255134B2Publication Date: 2016-02-09
- Inventor: Carola Leuschner , Hector Alila
- Applicant: Esperance Pharmaceuticals, Inc. , BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
- Applicant Address: unknown Baton Rouge US LA Baton Rouge
- Assignee: Esperance Pharmaceuticals, Inc.,Board of Supervisors of Louisana State University and Agricultural and Mechanical College
- Current Assignee: Esperance Pharmaceuticals, Inc.,Board of Supervisors of Louisana State University and Agricultural and Mechanical College
- Current Assignee Address: unknown Baton Rouge US LA Baton Rouge
- Agency: Pillsbury Winthrop Shaw Pittman LLP
- Main IPC: C07K14/59
- IPC: C07K14/59 ; C07K7/08 ; A61K38/24 ; A61K45/06
Abstract:
The invention relates to fusion constructs, methods of using fusion constructs and methods of treating undesirable or aberrant cell proliferation or hyperproliferative disorders, such as tumors, cancers, neoplasia and malignancies.
Public/Granted literature
- US20140255513A1 LYTIC DOMAIN FUSION CONSTRUCTS AND METHODS OF MAKING AND USING SAME Public/Granted day:2014-09-11
Information query
